VirTra (VTSI) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $6.1 million, down 41% year-over-year, mainly due to delayed federal funding and government contracts.

• Gross margin reached a record 91%, driven by operational efficiencies, favorable revenue mix, and a higher proportion of STEP and service contracts.

• Net income increased 17% to $1.2 million ($0.11 per diluted share), despite lower revenue.

• Bookings doubled quarter-over-quarter to $5.9 million, and backlog stood at $313.8 million as of June 30, 2024.

• Strategic initiatives included the launch of the V-XR platform, expansion into healthcare, and appointment of Brandon Cox as CTO.

Financial highlights

• Q2 2024 gross profit was $5.5 million (91% margin), compared to $5.9 million (57%) in Q2 2023.

• Operating income was $1.1 million, down from $1.9 million year-over-year.

• Adjusted EBITDA was $1.6 million, down from $2.6 million in Q2 2023.

• Unrestricted cash and equivalents were $18.4 million at quarter-end; working capital was $34.8 million.

• STEP and service contracts contributed 40% of Q2 revenue, supporting higher margins.

Outlook and guidance

• Management expects most new capital bookings from H1 2024 to convert to revenue in 2024, with a strong sales pipeline for the second half.

• Gross margin is expected to normalize to the low 60% range, with potential dips to the high 50s as new products launch.

• V-XR platform to begin shipping by end of Q3 2024, targeting law enforcement, military, healthcare, and education.

• Current capital resources are expected to support operations for more than 12 months.

• Anticipates growth in healthcare and military segments as new laws and budgets drive demand.